Skip to main content
. 2020 Apr 8;13(5):923–931. doi: 10.1111/cts.12779

Figure 2.

Figure 2

Effects of zanubrutinib on ECG parameters. (a) Change‐from‐baseline heart rate (ΔHR) across time points and (b) mean change from baseline in QTcF interval over time using Fridericia’s formula (ΔQTcF). Study participants received zanubrutinib 160 mg (open squares), zanubrutinib 480 mg (open triangles), moxifloxacin (open diamonds), or placebo (open circles).